News
-
Saudis back Cambridge corrosion technology in $5m round
CorrosionRADAR Ltd has won investment from Saudi Aramco Energy Ventures (SAEV) in a $5 million funding round to drive its next phase of global growth... Read More
-
Cambridge University’s Impulse programme mines millionaire tech elite
A Cambridge University programme has mined a glittering cohort of world beating companies run by alumni that have together attracted over £53 million... Read More
-
AstraZeneca shares rocket on stunning 2020 results
AstraZeneca’s share price took off in the UK today as the Cambridge-based Big Biotech produced a phenomenal set of results for the 2020 full year... Read More
-
Hexcel rolls with the punches
US industrial heavyweight Hexcel Corporation, which has a major composites operation in Duxford, has taken an anticipated financial battering... Read More
-
Charco Neurotech raises seed cash for wearable Parkinson’s device
A startup founded by Cambridge entrepreneurs has developed a wearable, non evasive device to ease the symptoms of Parkinson’s disease and raised £... Read More
-
New fund to help close £6.5bn private equity gap
The University of Cambridge has launched its eighth Enterprise Fund, managed by university spinout fund manager Parkwalk in conjunction with... Read More
-
Judge wins verdict on two counts in FT MBA rankings
Cambridge Judge Business School has been named in the world’s top 16 MBA programmes and UK No.1 for one-year MBA programmes in the global FT rankings... Read More
-
SDI shares soar on trading update
Shares in Cambridge based SDI Group plc opened 27 per cent higher today to 153p after a trading update flagged significantly higher revenues and... Read More
-
Millions invested in Optibrium growth push
Optibrium™, a Cambridge-based developer of software for drug discovery, has raised millions from Kester Capital, a leading UK mid-market private... Read More
-
Qualcomm stockholders cash in on fabulous Q1
Qualcomm Incorporated, which has multiple locations in Cambridge, has revealed a blockbusting first quarter of 2021 to December 27 – and shareholders... Read More
-
£20m boost as Illumina unveils more genomics startups for Cambridge and US accelerator
Illumina, Inc. whose European research HQ is in Cambridge, has chosen nine new genomics companies to join the second global funding cycle of Illumina... Read More
-
New antigen test fast-tracked globally for range of diseases
Cambridge’s Avacta Group and Bedford-bsed ally Mologic have joined forces to accelerate commercialisation of a novel diagnostic test identified as... Read More
-
Redcat bounce with £200m investment for UK pub venture
East of England law firm Birketts has proved LA influential by advising Redcat Pub Company Limited on a private equity investment of £200 million... Read More
-
£65m life science building approved for Cambridge Biomedical Campus
Liberty Property Trust and Countryside Properties, the developers of the Cambridge Biomedical Campus expansion, have been granted planning consent... Read More
-
New wave of 13,500 jobs in Felixstowe freeport bid
A new freeport for the East of England could create 13,500 jobs in the region as part of an investment of more than half-a-billion pounds. The... Read More
-
Women entrepreneurs still facing capital punishment
Women entrepreneurs in the UK are only receiving one per cent of all available venture capital funding in the UK and the issue is being addressed by... Read More
-
Australian world leader adopts CMR’s surgical robotics technology
Cambridge surgical robotics pioneer CMR has broken into the lucrative Australian market. Australia has become the fifth global market to introduce... Read More
-
Inivata takes Series C to $60m with fresh $35m raise
Cambridge liquid biopsy business Inivata has raised $35 million in a second close of a Series C financing round. The round was led by Soleus... Read More
-
Broadband legend wades out of hot water with Webb feat
Cambridge Broadband Networks Group (CBNG) is continuing its bounceback from last year’s administration process by further strengthening its top team... Read More
-
GW Pharma swings to Jazz for $7.2bn
Cambridge business GW Pharmaceuticals, whose medicines are based on cannabis, has agreed to sell to the Irish company Jazz Pharmaceuticals – which... Read More